<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Our manuscript proposes recommendations to standardise implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) programming practice in New Zealand (NZ) and provides a review of the literature behind such an initiative </plain></SENT>
<SENT sid="1" pm="."><plain>BACKGROUND: Shocks have traditionally been the mainstay of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy for ventricular tachyarrhythmia </plain></SENT>
<SENT sid="2" pm="."><plain>There is substantial evidence to suggest shocks may cause psychological harm, are often painful and may increase hospitalisation for <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Shock therapy may be reduced by avoiding unnecessary therapy of non-sustained <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, utilising anti-<z:hpo ids='HP_0001649'>tachycardia</z:hpo> pacing to terminate <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and by using algorithms to identify non-ventricular rhythms with rates overlapping therapy zones </plain></SENT>
<SENT sid="4" pm="."><plain>This manuscript outlines evidence-based strategies to safely reduce unnecessary shocks from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> and includes manufacturer-specific parameters for ease of practical use </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: These recommendations aim to optimise programming of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> devices in NZ </plain></SENT>
<SENT sid="6" pm="."><plain>Developed from a substantial evidence base they are intended to align national programming practice in the hope that we achieve fewer hospitalisations, improved quality of life and possibly achieve greater survival for our <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>-treated patients </plain></SENT>
</text></document>